Major malaria study leads WHO to revise treatment guidelines

Major malaria study leads WHO to revise treatment guidelines
The Chinese herb qinghao (Artemisia annua), which is processed to make the drug artesunate. Credit: tonrulkens on Flickr.

The results of the largest ever clinical trial among patients hospitalised with severe malaria - the Wellcome Trust-funded AQUAMAT study - have led the World Health Organisation (WHO) to revise its guidelines for the treatment of the disease in African children.

AQUAMAT - the 'African quinine versus artesunate malaria trial' - involved researchers across Africa, working in collaboration with scientists in Thailand and the UK. The randomised, controlled trial enrolled 5425 children hospitalised with severe malaria across nine African countries. It showed a 22.5 per cent reduction in mortality among patients treated with artesunate compared to those given the standard treatment of quinine.

In line with these findings, the WHO has now changed its treatment guidelines to recommend parenteral artesunate as first-line treatment in the management of severe malaria in African children. The disease remains a major killer, with these patients accounting for 90 per cent of the one million deaths that occur annually. Changing the first-line treatment from quinine to artesunate has the potential to save hundreds of thousands of children's lives across each year.

Professor Nick White of Oxford University, who led the study, says: "The AQUAMAT trial is a very important step in reducing preventable childhood death in the tropics. It is very gratifying for the many investigators to see their research findings being turned into a globally influential policy. If implemented this will save hundreds of thousands of young lives."

The AQUAMAT team has also been shortlisted as one of the three finalists in the category of Research Paper of the Year in the prestigious British Medical Journal Awards.

Dr Jimmy Whitworth, Head of International Activities at the Wellcome Trust, adds: "This is clearly an immensely important piece of work by Nick White and colleagues and an excellent example of how multicentre research can be conducted across many countries and even continents. This has provided the rigorous evidence necessary to inform the WHO's revised guidelines and we hope this will have a dramatic effect on the lives of children across the African continent."

add to favorites email to friend print save as pdf

Related Stories

Rectal artemisinins rapidly eliminate malarial parasites

Mar 28, 2008

Artemisinin-based suppositories can help ‘buy time’ for malaria patients who face a delay in accessing effective, injectable antimalarials, according to research published in the online open access journal BMC Infectious Di ...

Recommended for you

Sierra Leone faces criticism over Ebola shutdown

3 hours ago

Sierra Leone began the second day of a 72-hour nationwide shutdown aimed at containing the spread of the deadly Ebola virus on Saturday amid criticism that the action was a poorly planned publicity stunt.

Presence of peers ups health workers' hand hygiene

18 hours ago

(HealthDay)—The presence of other health care workers improves hand hygiene adherence, according to a study published in the October issue of Infection Control and Hospital Epidemiology.

Sierra Leone streets deserted as shutdown begins

Sep 19, 2014

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

Sep 19, 2014

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

User comments